Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
Clémence Lacroix(Inserm), Joëlle Micallef(Institut de Neurosciences des Systèmes), François Montastruc(Centre d’Investigation Clinique 1436), Youssef Bennis(Centre Hospitalier Universitaire Amiens-Picardie), Véronique Pizzoglio(Hospices Civils de Lyon), Farid Kheloufi(Assistance Publique Hôpitaux de Marseille)
Cited by 60
Related Papers
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48
Non-targeted screening for novel psychoactive substances among agitated emergency department patients
|Clinical Toxicology|2016|42
Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?
|Revue Neurologique|2023|32
Serious Neurological Adverse Events of Ceftriaxone
|Antibiotics|2021|29